Dr. Maria Blaze is a pharmacist who is specialized in Psychiatric in Danville, Illinois. Patients can reach her at 1900 E Main St, Danville or contact her on 217-554-3860. Active license number of Dr. Maria Blaze is 55587 for Psychiatric in Texas. Dr. Maria Blaze is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Dr. Maria Blaze speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Maria Blaze
Specialization:
Psychiatric
Credentials:
PHARMD
Gender:
Female
Location:
1900 E Main St, Danville, Illinois, 61832-5100
Phone:
217-554-3860
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Maria Blaze are as mentioned below.
NPI Number:
1528448339
NPI Enumeration Date:
05 Jun, 2015
NPI Last Update On:
07 Mar, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Maria Blaze are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
55587
Texas
Primary
Pharmacist
55587
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3495 Bailey Ave, (119) Buffalo, New York
Zip:
14215-1129
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Maria Blaze at 1900 E Main St, Danville, Illinois or can call on phone at 217-554-3860.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.